TrialCancer2016
A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer.
Helen Chow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papertrialcites it
TrialCancer2016
Helen Chow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.